Reliant Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$652K Buy
544
+8
+1% +$8.17K 0.23% 38
2026
Q1
$493K Sell
536
-16
-3% -$16.2K 0.24% 30
2025
Q4
$593K Sell
552
-61
-10% -$58.3K 0.24% 35
2025
Q3
$468K Sell
613
-366
-37% -$272K 0.18% 38
2025
Q2
$763K Sell
979
-22
-2% -$17.1K 0.33% 36
2025
Q1
$827K Sell
1,001
-10
-1% -$8.32K 0.43% 33
2024
Q4
$780K Sell
1,011
-376
-27% -$311K 0.34% 38
2024
Q3
$1.23M Buy
1,387
+59
+4% +$53K 0.58% 35
2024
Q2
$1.2M Sell
1,328
-10
-0.7% -$8K 0.57% 37
2024
Q1
$1.04M Hold
1,338
0.49% 37
2023
Q4
$780K Sell
1,338
-44
-3% -$25.7K 0.4% 39
2023
Q3
$742K Sell
1,382
-50
-3% -$25.8K 0.43% 37
2023
Q2
$672K Hold
1,432
0.39% 39
2023
Q1
$492K Sell
1,432
-70
-5% -$23.6K 0.31% 39
2022
Q4
$549K Sell
1,502
-130
-8% -$46.1K 0.33% 36
2022
Q3
$528K Buy
1,632
+315
+24% +$99.8K 0.38% 33
2022
Q2
$427K Hold
1,317
0.3% 34
2022
Q1
$377K Hold
1,317
0.19% 41
2021
Q4
$364K Sell
1,317
-165
-11% -$41.8K 0.15% 50
2021
Q3
$342K Hold
1,482
0.17% 49
2021
Q2
$340K Hold
1,482
0.16% 54
2021
Q1
$277K Hold
1,482
0.14% 50
2020
Q4
$250K Buy
1,482
+59
+4% +$8.81K 0.13% 50
2020
Q3
$211K Buy
1,423
+165
+13% +$25.5K 0.14% 57
2020
Q2
$207K Buy
+1,258
New +$193K 0.15% 40
2018
Q2
Sell
-34,979
Closed -$2.71M 52
2018
Q1
$2.71M Buy
34,979
+505
+1% +$40.7K 2.01% 32
2017
Q4
$2.91M Buy
+34,474
New +$2.93M 1.99% 32

Other funds holding LLY

Reliant Investment Management's LLY Position: Q2 2026 in Review

Reliant Investment Management increased its Eli Lilly (LLY) stake by 1.5% in Q2 2026, buying an estimated $8.17K and bringing the position to 544 shares worth $652K. The position accounts for 0.23% of the portfolio, ranked #38.

Reliant Investment Management first reported a position in LLY in Q4 2017 and has held it in 27 quarters since. The position peaked at $2.91M in Q4 2017. 1,674 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Reliant Investment Management held 544 shares of Eli Lilly worth $652K as of Q2 2026.
  • Reliant Investment Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.23% of Reliant Investment Management's portfolio in Q2 2026, its #38 holding.
  • Reliant Investment Management first reported a position in Eli Lilly in Q4 2017 and has held it in 27 quarters since.
  • Reliant Investment Management's Eli Lilly position peaked at $2.91M in Q4 2017.
  • 1,674 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Reliant Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.